Cargando…
Myocarditis following AstraZeneca (an adenovirus vector vaccine) COVID‐19 vaccination: A case report
Coronavirus disease‐19 (COVID‐19) vaccines are massively administered globally and some adverse events, such as myocarditis, are being reported. Most of the reported cases of post‐vaccination myocarditis have occurred following mRNA vaccinations. However, there have also been recent reports of myoca...
Autores principales: | Hassanzadeh, Shakiba, Sadeghi, Somayeh, Mirdamadi, Ahmad, Nematollahi, Alireza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011044/ https://www.ncbi.nlm.nih.gov/pubmed/35441011 http://dx.doi.org/10.1002/ccr3.5744 |
Ejemplares similares
-
AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021) -
Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
Publicado: (2021) -
Vaccin Oxford/AstraZeneca, mode d’emploi
por: Dalmat, Yann-Mickael
Publicado: (2021) -
Oxford–AstraZeneca COVID-19 vaccine efficacy
por: Knoll, Maria Deloria, et al.
Publicado: (2021) -
AstraZeneca COVID-19 vaccine-related thromboembolism
Publicado: (2021)